EV/EBITDA:
-92.03+0.57(+0.62%)Summary
- As of today, TVTX EV/EBITDA is -92.03, with a rise of +0.57 (+0.62%) during the most recent trading session on December 1, 2025.
- Over the past year, TVTX EV/EBITDA has dropped by -84.30 (-1090.56%).
- TVTX EV/EBITDA is now -16045.61% below its all-time high of -0.57.
Performance
TVTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TVTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +0.6% | -0.6% | -0.6% |
| 1M1 Month | -0.1% | +0.1% | +0.1% |
| 3M3 Months | -553.2% | +89.9% | +93.9% |
| 6M6 Months | -1029.2% | +121.3% | +126.7% |
| YTDYTD | -1159.0% | +107.4% | +102.0% |
| 1Y1 Year | -1090.6% | +76.3% | +79.8% |
| 5Y5 Years | -331.3% | +229.4% | +50.5% |
TVTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -84.75 | -8.6% | -95.30 | +3.4% |
| 3M | 3-Month | -14.09 | -553.2% | -95.30 | +3.4% |
| 6M | 6-Month | -7.44 | -1137.0% | -95.30 | +3.4% |
| 1Y | 1-Year | -6.74 | -1265.4% | -95.30 | +3.4% |
| 3Y | 3-Year | -0.57 | >-9999.0% | -95.30 | +3.4% |
| 5Y | 5-Year | -0.57 | >-9999.0% | -95.30 | +3.4% |
| All-Time | All-Time | -0.57 | >-9999.0% | -392.61 | +76.6% |
TVTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -92.03(-1159.0%) |
| 2024 | -7.31(-335.1%) |
| 2023 | -1.68(+67.1%) |
| 2022 | -5.11(+65.3%) |
| 2021 | -14.74(+42.7%) |
| Date | Value |
|---|---|
| 2020 | -25.72(+38.0%) |
| 2017 | -41.47(-51.5%) |
| 2016 | -27.38(+0.5%) |
| 2015 | -27.51(-429.0%) |
| 2014 | -5.20(+8.8%) |
| 2013 | -5.70 |
FAQ
- What is Travere Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Travere Therapeutics, Inc.?
- What is TVTX EV/EBITDA year-to-date change?
- What is Travere Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Travere Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TVTX is -92.03
What is the all-time high EV/EBITDA for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high EV/EBITDA is -0.57
What is TVTX EV/EBITDA year-to-date change?
Travere Therapeutics, Inc. EV/EBITDA has changed by -84.72 (-1158.96%) since the beginning of the year
What is Travere Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TVTX EV/EBITDA has changed by -84.30 (-1090.56%)